| Literature DB >> 16841268 |
Naoko Ishibashi1, In-Sam Park, Yukiko Takahashi, Mitsunori Nishiyama, Yasue Murakami, Katsuhiko Mori, Shigekazu Mimori, Makoto Ando, Yukihiro Takahashi, Toshio Nakanishi.
Abstract
We report a case of a patient with severe heart failure after Fontan procedure in whom carvedilol was very effective. A 27-year-old man had intractable congestive heart failure due to severe ventricular dysfunction after Fontan operation. Central venous pressure was elevated to 29 mmHg. A right-to-left shunt was noted across a large collateral vessel between the innominate vein and the pulmonary vein. He was administered carvedilol (initial dose, 2 mg/day; maximum dose, 30 mg/day). Cardiac catheterization performed 1 year after carvedilol administration revealed a decrease in atrial pressure and improvement of ventricular function. He underwent a conversion operation to total cavopulmonary connection (TCPC) and ligation of a collateral vein communicating with the innominate and pulmonary veins. Carvedilol may be a legitimate treatment before TCPC conversion or heart transplantation for the high-risk group of patients with a failed Fontan circulation.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16841268 DOI： 10.1007/s00246-006-1105-x
Source DB: PubMed Journal: Pediatr Cardiol ISSN： 0172-0643 Impact factor: 1.655